Metabolic Dysfunction-Associated Steatotic Liver Disease: Global Epidemiology, Patient-Reported Outcomes, and Economic Impact Association of Metabolic Dysfunction-Associated Steatohepatitis with Metabolic- Related Diseases: Diabetes, Prediabetes, and Obesity Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with Extrahepatic Cancers and Sarcopenia Metabolic Liver Disease Beyond the Liver: Association of Metabolic Dysfunction- Associated Steatotic Liver Disease with Cardiovascular and Renal Diseases Noninvasive Testing for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis Algorithms for Risk Stratification in Patients with Metabolic Dysfunction- Associated Steatohepatitis Management of Metabolic Dysfunction-Associated Steatotic Liver Disease with Lifestyle Modification Treatment of Modifiable Risks in Metabolic Dysfunction-Associated Steatotic Liver Disease: Drugs Targeting Obesity and Type 2 Diabetes Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis Special Populations: Hepatocellular Carcinoma Risk and Liver Transplantation Special Population: Lean MASH Special Population: A Global Perspective on Metabolic Dysfunction-Associated Alcohol-Related Liver Disease What's New in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis Metabolic Dysfunction-Associated Steatohepatitis in the Middle East: Clinical Challenges and Strategies to Bridge the Gap Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.